Compare TG Therapeutics Inc (TGTX) vs Tencent Music Entertainment Group - ADR (TME) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Tencent Music Entertainment Group - ADR — how do they compare? TG Therapeutics Inc trades at $55.14 (market cap $8.16B), while Tencent Music Entertainment Group - ADR trades at $8.38 (market cap $12.83B). The key difference: Tencent Music Entertainment Group - ADR is the larger of the two by market cap, and Tencent Music Entertainment Group - ADR pays a 3.02% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold TG Therapeutics Inc for 16 Days and Tencent Music Entertainment Group - ADR for 67 Days on average.
| TGTX | TME | |
|---|---|---|
Market Cap | $8.16B | $12.83B |
Volume | 1,735,121 | 3,618,478 |
Sector | Health | Media |
52-Week High | $59.06 | $23.71 |
52-Week Low | $26.94 | $7.74 |
Typical Hold Time | 16 Days | 67 Days |
Enterprise Value | $8.37B | $10.77B |
Dividend Yield | — | 3.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TG Therapeutics (TGTX) trades at $54.80, up 3.49% today, but faces a bearish technical signal with recent earnings misses. Revenue growth is strong, with 2026 guidance raised to $950M for BRIUMVI, and net income margins exceed 55%. However, cash flow was negative in 2025, and a shareholder litigation investigation adds near-term uncertainty.
The outlook is mixed: analyst consensus is bullish with an $80.50 price target, but execution risks and earnings volatility persist. Upside hinges on BRIUMVI market share gains and subcutaneous formulation progress, while legal and competitive pressures pose threats to shareholder value.
Tencent Music Entertainment (TME) trades at $8.38, up 4.88% today, but technical indicators signal a bearish trend with moving averages and ADX suggesting selling pressure. Fundamentally, the company shows strong profitability with 26.28% net margin and attractive valuation at 9.33 P/E ratio. Recent Q2 2026 earnings beat expectations with $0.25 EPS, though revenue growth remains modest. The company recently completed a $1 billion notes offering to strengthen its financial position.
TME presents a compelling value opportunity with discounted valuation metrics and solid profitability, though facing competitive pressures from ByteDance's Soda Music. Analyst consensus leans neutral with $12.50 price target representing 49% upside potential. Key risks include user churn among casual listeners and rising operating expenses needed to retain users in the competitive music streaming landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Tencent Music Entertainment Group - ADR
TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →
